On September 1, 2023, Forte Biosciences, Inc. announced that it has issued an investor presentation to its shareholders in connection with its 2023 annual shareholders meeting scheduled to be held on September 19, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.74 USD | +3.31% | -1.39% | -13.59% |
Mar. 18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Camac Partners Provides Information to Shareholders | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.59% | 26.07M | |
-2.62% | 103B | |
+1.50% | 95.28B | |
+1.46% | 22.15B | |
-15.73% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.18% | 13.68B | |
+33.58% | 12.17B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences Issues an Investor Presentation to Shareholders